Wherever you live, Mr Trump’s presidency will affect you. Over the next four years, we will report on and analyse the effects ...
But, if you’re in need of the perfect set of songs to satisfy both divisions of the muso world, then a collection of covers of the Eagles that are better than the originals is probably as welcome as a ...
Tone is everything, and this year we decided to address our cover editorial to a particular set of Trump voters—not MAGA diehards or aggressive nationalists, but pragmatic, Economist-reading ...
THIS WEEK we had just one cover: our endorsement for America ... left-wing ideas and is campaigning near the centre. If The Economist had a vote, we would cast it for Ms Harris.
Bloomberg Business Week magazine has re-launched as a premium monthly print ... BLOOMBERG BUSINESSWEEK or a subscription of your desired length, delivered worldwide. Current issues sent same day up to ...
Gunn is set to grace the cover of Oct. 27 issue of Stellar, which boasts that it is “Australia’s most-read Sunday magazine ... an Australian news and current affairs show.
On October 23, Ye—the rapper formerly known as Kanye West—shared a photo of the cover of his upcoming album Bully, his third this year, on Instagram. Later, in typical Ye fashion, he ...
That’s right. Raygun is back, baby. On the cover of the upcoming edition of Australia’s most-read Sunday magazine, it says it will reveal “What Raygun did next…” Rachael Gunn appears with her hands on ...
Rachael “Raygun” Gunn, who was mercilessly mocked for her break dancing performance at the Paris Olympics, appears on the cover of this week’s edition of the Australian magazine Stellar.
We had one worldwide cover this week. And it featured some very good news. GLP-1 receptor agonists such as Ozempic and Wegovy started as treatments for diabetes and obesity. That alone would have ...
Every day seems to bring more exciting news. First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to treat cardiovascular and ...
Chart: The Economist What is more ... So far health insurers and governments have been reluctant to cover the cost of using GLP-1s for weight loss (a smaller dose is prescribed for diabetes).